DOCS Expands Clinical AI Tools Across Three Major U.S. Health Systems
Doximity (DOCS) expanded its AI tools to NewYork-Presbyterian, Columbia University, and Weill Cornell Medicine, including Doximity Ask and Scribe. DOCS stock rose 0.4% post-announcement but is down 24.7% year-to-date. The collaboration aims to integrate AI into clinical workflows, potentially boosting DOCS's growth prospects. DOCS has a market cap of $5.95 billion.
How this was made

The 30-second read
Why it matters
The expanded collaboration could increase product usage and open doors to additional hospital systems, supporting longer‑term growth.
Market read
First‑report of a modest partnership that nudges DOCS shares higher; limited immediate trading impact but reinforces AI‑health sector narrative.
What to watch
Potential integration challenges with Epic EHR and competition from other AI health platforms.
Background
Doximity (DOCS) provides a digital platform for physicians, recently adding AI tools for decision support and documentation.
Ticker impact
Doximity announced an expanded AI‑clinical decision support and documentation partnership with NewYork‑Presbyterian, Columbia University and Weill Cornell Medicine.
likely modest upward pressure as investors price in expanded enterprise adoption
The announcement is the first report of the expanded collaboration and the stock already inched up 0.4% on the news.
Market effects
Highlights growing demand for AI‑enabled clinical decision support in U.S. health systems.
Positive for U.S. healthcare technology providers.
Limited to AI‑healthcare niche; no broad market effect.
Counterpoint
The modest scale of the deal may not materially move revenue, limiting upside.
Key entities
- health systemNewYork-Presbyterian
Partner in the AI tool rollout.
- academic medical centerColumbia University
Partner in the AI tool rollout.
- academic medical centerWeill Cornell Medicine
Partner in the AI tool rollout.



